ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2911 - 2925 of 5996 products
Roche Gets Speedy China Approval for New Lung Cancer Treatment
$5.00
Available
Bio-Thera BLA for Humira Biosimilar Accepted in China
$5.00
Available
China Biologic Management Makes $3.9 Billion Take-Private Offer
$5.00
Available
Harbour BioMed in $350 Million Deal for Sichuan Kelun PD-L1 Candidate
$5.00
Available
Harbin Gloria Partners Four of its Drug Candidates in $53 Million Agreement
$5.00
Available
Shanghai ChemPartner Closes Reverse Merger with Quantum
$5.00
Available
Adlai Nortye of Hangzhou Opens Boston Innovation Center
$5.00
Available
YiChang HEC Pharm Raises $400 Million from Blackstone Group
$5.00
Available
Sirnaomics to Start US Trial of siRNA Treatment for Bile Duct Cancer
$5.00
Available
Buck Institute, Insilico and Juvenescence Form Napa to Develop Anti-Aging Drug
$5.00
Available
CrownBio Acquires Rights to Drug Development Models from Shanghai Model Organisms
$5.00
Available
CANbridge Approved for China Phase Ib/III Trial of Esophageal Cancer Drug
$5.00
Available
Sihuan Pharma Starts China Phase II Lung Cancer Trial
$5.00
Available
Haisco Invests $10 Million in Pneuma Respiratory; Acquires Rights to Asthma/COPD Inhaler
$5.00
Available
Ascletis and BeiGene Trade Lower Following Hong Kong IPOs
$5.00
Available